Alex Cacovean

Alex Cacovean, MD has extensive work experience in the field of clinical development and medical research. Alex currently holds the position of VP, Clinical Development at Biomea Fusion, where they have been since 2021. Prior to this, they served as the Executive Medical Director at the same company from July 2021 to January 2023.

Before joining Biomea Fusion, Dr. Cacovean worked at Iovance Biotherapeutics, Inc. as a Senior Medical Director from February 2020 to June 2021. Alex also held the position of Medical Director at the same company from August 2018 to February 2020.

Dr. Cacovean's experience also includes roles at Pharmacyclics as the Director of Clinical Operations from March 2017 to August 2018. Alex previously served as an Associate Director from February 2015 to March 2017, a Senior Clinical Trial Manager from February 2014 to February 2015, and a Clinical Trial Manager from November 2012 to February 2014.

Earlier in their career, Dr. Cacovean worked at PPD as a Clinical Team Manager from May 2011 to November 2012. Alex started their career at PPD as a Sr. Clinical Research Associate in January 2008 and later became a Clinical Research Associate from January 2007 to January 2008.

Dr. Cacovean also gained experience at Henry Ford Health System as a Study Coordinator from June 2005 to January 2007. In this role, they were responsible for coordinating and overseeing clinical trials in various hematological and oncological indications.

Overall, Dr. Alex Cacovean has a diverse background in clinical development and medical research, with a progressive career path in various leadership positions.

Alex Cacovean, MD received their MD degree in Medicine from the University of Medicine and Pharmacy Cluj-Napoca in 2005.